GeoVax Labs (GOVX) Return on Equity [ROE] (2009 - 2026)
GeoVax Labs (GOVX) reported Return on Equity [ROE] of -735.21% for Q2 2026, down 272.38 percentage points from -462.82% a year earlier.
Powered by 
Analysis
GeoVax Labs (GOVX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, GeoVax Labs posted Return on Equity [ROE] of -483.79%, down 21.47 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -409.78 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -462.31% in FY2024 (-301.84 pp), -160.47% in FY2023 (-69.90 pp), -90.57% in FY2022 (+178.51 pp) and -269.08% in FY2021 (-195.08 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q3 2024.
- Year over year, Return on Equity [ROE] gained in two of the last six quarters, with an average year-over-year change of -52.12 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2025 (a gain of 576.52 percentage points); the low point was Q1 2024 (a drop of 891.79 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | GeoVax Labs | 502,172.77 | -12.01 Mn | - | -1,812.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,812.03% |
| Mar 31, 2026 | -989.56% |
| Dec 31, 2025 | -491.62% |
| Sep 30, 2025 | -654.97% |
| Jun 30, 2025 | -462.82% |
| Mar 31, 2025 | -378.48% |
| Dec 31, 2024 | -368.82% |
| Sep 30, 2024 | -785.26% |
| Mar 31, 2024 | -955.00% |
| Dec 31, 2023 | -348.95% |
| Sep 30, 2023 | -180.79% |
| Jun 30, 2023 | -96.52% |
| Mar 31, 2023 | -63.20% |
| Dec 31, 2022 | -48.03% |
| Sep 30, 2022 | -75.03% |
| Jun 30, 2022 | -103.82% |
| Mar 31, 2022 | -249.53% |
| Dec 31, 2021 | -167.60% |
| Sep 30, 2021 | -33.83% |
| Jun 30, 2021 | -24.71% |
API Access
GeoVax Labs Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();